EW HEALTHCARE PARTNERS FUND 2 L.P. 13D and 13G filings for TELA Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-28 4:06 pm Unchanged | 2024-10-24 | 13G | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 4,110,709 10.440% | 0 (Unchanged) | Filing |
| 2024-02-14 06:35 am Purchase | 2023-12-31 | 13G | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 4,110,709 16.790% | 5,000 (+0.12%) | Filing |
| 2022-08-22 3:19 pm Purchase | 2022-08-17 | 13D | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 4,105,709 21.430% | 500,000 (+13.87%) | Filing |
| 2022-07-18 4:20 pm Purchase | 2022-07-13 | 13D | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 3,605,709 24.760% | 150,000 (+4.34%) | Filing |
| 2022-06-01 1:12 pm Purchase | 2022-05-25 | 13D | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 3,455,709 23.730% | 156,210 (+4.73%) | Filing |
| 2022-02-28 3:00 pm Purchase | 2022-02-23 | 13D | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 3,299,499 22.750% | 814,395 (+32.77%) | Filing |
| 2022-01-19 12:58 pm Purchase | 2022-01-19 | 13D | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 2,485,104 17.130% | 653,056 (+35.65%) | Filing |
| 2021-09-21 5:29 pm Purchase | 2021-09-15 | 13D | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 1,832,048 12.660% | 153,335 (+9.13%) | Filing |
| 2021-05-18 4:43 pm Purchase | 2021-05-18 | 13D | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 1,678,713 11.620% | 203,420 (+13.79%) | Filing |
| 2021-02-18 5:13 pm Purchase | 2020-12-31 | 13D | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 1,475,293 10.220% | 706,062 (+91.79%) | Filing |